James Patrick Tursi's Net Worth

$2.69 Million

Estimate Recalculated Mar 4, 2024 09:23PM EST

Who is James Patrick Tursi?

James Patrick Tursi has an estimated net worth of $2.69 Million. This is based on reported shares across multiple companies, which include ANTARES PHARMA, INC., Endo International plc, AGILE THERAPEUTICS INC, Aralez Pharmaceuticals Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, and NeuroBo Pharmaceuticals, Inc..

SEC CIK

James Patrick Tursi's CIK is 0001527710

Past Insider Trading and Trends

2014 was James Patrick Tursi's most active year for acquiring shares with 12 total transactions. James Patrick Tursi's most active month to acquire stocks was the month of May. 2014 was James Patrick Tursi's most active year for disposing of shares, totalling 14 transactions. James Patrick Tursi's most active month to dispose stocks was the month of October. 2014 saw James Patrick Tursi paying a total of $1,396,916.48 for 203,312 shares, this is the most they've acquired in one year. In 2014 James Patrick Tursi cashed out on 172,778 shares for a total of $3,016,691.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ANTARES PHARMA, INC. No price found

EVP, Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
45.2K
$2.92
$131,998.60
45.2K
Jun 13
Form 4
—
0
—
—
0
Aug 6
Form 3
—
0
—
—
0
No matching records found

Endo International plc (ENDPQ) Snapshot price: $0.0007

Executive VP, Global R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-280.37K
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

AGILE THERAPEUTICS INC (AGRX) Snapshot price: $1.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.99%
670
—
—
2.07K
Jun 9
Form 4
+78.20%
24.51K
—
—
55.85K
Jun 8
Form 4
+74.62%
13.39K
—
—
31.34K
Jun 9
Form 4
—
0
—
—
0
Jun 6
Form 4
∞
17.95K
—
—
17.95K
Jun 7 - Jun 8
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

Aralez Pharmaceuticals Inc. No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.72%
-9.35K
$0.52
-$4,881.53
242.05K
Scheduled
May 14
Form 4
-2.31%
-5.95K
$1.70
-$10,115.00
251.4K
Scheduled
Mar 19
Form 4
-3.73%
-9.96K
$2.50
-$24,917.93
257.35K
Scheduled
Oct 2
Form 4
+45.18%
83.19K
—
—
267.31K
May 11
Form 4
+2.65%
4.75K
$2.11
$10,022.50
184.12K
Mar 15
Form 4
+5.90%
10K
$3.75
$37,500.00
179.37K
May 20
Form 4
+2.73%
4.5K
$3.79
$17,037.45
169.37K
May 16
Form 4
+40.31%
47.37K
—
—
164.87K
Mar 17
Form 4
+283.52%
86.86K
—
—
117.5K
Feb 12
Form 4
∞
30.64K
—
—
30.64K
Feb 5
No matching records found

AUXILIUM PHARMACEUTICALS INC No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-32.63K
$36.53
-$1,067,991.08
0
Jan 29
Form 4
-8.99%
-3.15K
$26.62
-$265,997.15
31.9K
Nov 25
Form 4
-9.43%
-3.65K
$25.01
-$1,282,581.91
35.05K
Nov 20 - Nov 21
Form 4/A
+92.52%
27.7K
—
—
57.64K
Feb 7 - Feb 18
Form 4/A
+35.35%
6.38K
—
—
24.41K
Feb 18
Form 4
+111.85%
20.17K
$28.30
-$19,923.20
38.2K
Feb 18
Form 4
-0.60%
-108.00
$26.80
-$2,894.40
18.03K
Feb 17
Form 4
-10.12%
-2.04K
$23.68
-$48,378.24
18.14K
Feb 7
Form 4
+728.60%
16.71K
$18.30
-$7,795.80
19.01K
Feb 7
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Aug 8
Form 3
—
0
—
—
0
No matching records found